It has been shown to reduce hepatocellular carcinoma cell proliferation by targeting SOX9 and to suppress lung adenocarcinoma cell tumorigenesis in vivo by binding to PRC1 [28,32]. Here, PRC1 is linked to hepatocellular carcinoma.